State-of-the-art R&D support from conceptualization, research to product development

Heterologous expression

2 5   heterWe offer our clients the utilization of our highly efficient in-house developed heterologous expression systems based on Actinomyces and Bacillus high-producing strains to service your needs. Our optimized high-producing industrial hosts allow for efficient heterologous expression of large gene clusters encoding complex biosynthesis of secondary metabolites, as well as for heterologous expression of target proteins for production of biopharmaceuticals or industrially relevant enzymes.

Please read more about our heterologous expression platform here...

European Medicines Agency (EMA) granted orphan medicinal product designation to its lead compound CAB1803 for Pantothenate-kinase-associated neurodegeneration (PKAN)

More >>
Within H2020 SME Innovation Associate project we invite a “Disease Model Development Manager” to join our team.

More >>
ABCloneTM is fast and efficient solution for cloning of large natural and synthetic DNA fragments. We provide ABCloneTM as a stand alone service for getting quickly your long DNA fragment sub-cloned into plasmid vector of your choice.

More >>
Acies Bio received the “Jesenko Award” from Biotechnical Faculty of University of Ljubljana. The award recognizes institutions for their outstanding research work in the field of biotechnology.

Scientists at ACIES BIO made a breakthrough innovation: high-value technology that uses unique and economic bioprocess to convert acid waste whey from dairy factories into high value animal feed products (vitamin B12) and clean water in the same process. Check out Whey2Value!

More >>